TY - JOUR
T1 - Characterization, Recombinant Production and Structure-Function Analysis of NvCI, A Picomolar Metallocarboxypeptidase Inhibitor from the Marine Snail Nerita versicolor
AU - Covaleda-Cortés, Giovanni
AU - Hernández, Martha
AU - Trejo, Sebastián Alejandro
AU - Mansur, Manuel
AU - Rodríguez-Calado, Sergi
AU - García-Pardo, Javier
AU - Lorenzo, Julia
AU - Vendrell, Josep
AU - Chávez, María Ángeles
AU - Alonso-Del-Rivero, Maday
AU - Avilés, Francesc Xavier
PY - 2019/8/29
Y1 - 2019/8/29
N2 - © 2019 by the authors. A very powerful proteinaceous inhibitor of metallocarboxypeptidases has been isolated from the marine snail Nerita versicolor and characterized in depth. The most abundant of four, very similar isoforms, NvCla, was taken as reference and N-terminally sequenced to obtain a 372-nucleotide band coding for the protein cDNA. The mature protein contains 53 residues and three disulphide bonds. NvCIa and the other isoforms show an exceptionally high inhibitory capacity of around 1.8 pM for human Carboxypeptidase A1 (hCPA1) and for other A-like members of the M14 CPA subfamily, whereas a twofold decrease in inhibitory potency is observed for carboxypeptidase B-like members as hCPB and hTAFIa. A recombinant form, rNvCI, was produced in high yield and HPLC, mass spectrometry and spectroscopic analyses by CD and NMR indicated its homogeneous, compact and thermally resistant nature. Using antibodies raised with rNvCI and histochemical analyses, a preferential distribution of the inhibitor in the surface regions of the animal body was observed, particularly nearby the open entrance of the shell and gut, suggesting its involvement in biological defense mechanisms. The properties of this strong, small and stable inhibitor of metallocarboxypeptidases envisage potentialities for its direct applicability, as well as leading or minimized forms, in biotechnological/biomedical uses.
AB - © 2019 by the authors. A very powerful proteinaceous inhibitor of metallocarboxypeptidases has been isolated from the marine snail Nerita versicolor and characterized in depth. The most abundant of four, very similar isoforms, NvCla, was taken as reference and N-terminally sequenced to obtain a 372-nucleotide band coding for the protein cDNA. The mature protein contains 53 residues and three disulphide bonds. NvCIa and the other isoforms show an exceptionally high inhibitory capacity of around 1.8 pM for human Carboxypeptidase A1 (hCPA1) and for other A-like members of the M14 CPA subfamily, whereas a twofold decrease in inhibitory potency is observed for carboxypeptidase B-like members as hCPB and hTAFIa. A recombinant form, rNvCI, was produced in high yield and HPLC, mass spectrometry and spectroscopic analyses by CD and NMR indicated its homogeneous, compact and thermally resistant nature. Using antibodies raised with rNvCI and histochemical analyses, a preferential distribution of the inhibitor in the surface regions of the animal body was observed, particularly nearby the open entrance of the shell and gut, suggesting its involvement in biological defense mechanisms. The properties of this strong, small and stable inhibitor of metallocarboxypeptidases envisage potentialities for its direct applicability, as well as leading or minimized forms, in biotechnological/biomedical uses.
KW - Biomedical applications
KW - Biotechnological
KW - Carboxypeptidase
KW - Nerita versicolor
KW - Picomolar inhibition
KW - Proteinaceous inhibitor
KW - Recombinant production
UR - http://www.mendeley.com/research/characterization-recombinant-production-structurefunction-analysis-nvci-picomolar-metallocarboxypept
U2 - 10.3390/md17090511
DO - 10.3390/md17090511
M3 - Article
C2 - 31470614
SN - 1660-3397
VL - 17
JO - Marine Drugs
JF - Marine Drugs
IS - 9
M1 - 511
ER -